McMaster University scientist Dr. Sheila Singh has joined what the Terry Fox Research Institue is calling a national “dream team” assembled to find new treatments for the most common and deadly form of brain cancer among adults. Singh, who recently identified an abnormal stem cell that may drive the formation of brain tumours and is believed to be behind tumour recurrence and relapse, said she hopes the national team will use cancer stem cell models to target the cells responsible for treatment evasion and find therapies to tackle them.
For more information, please see the full article at the Hamilton Spectator.
